BiotechTube
IDL Diagnostics

IDL Diagnostics

Stockholm, Sweden
idldiagnostics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $9.2M

Overview

IDL Diagnostics, formerly known as AroCell, is a commercial-stage diagnostics company specializing in cancer monitoring. Its core technology is based on the Thymidine Kinase 1 (TK1) biomarker, offered in formats like the UBC Rapid point-of-care test and the TK 210 ELISA for automated platforms. The company is actively commercializing its products through distributor partnerships in Asia and Europe while engaging in clinical studies to expand the utility of its TK1 assays across various cancer types.

OncologyInfectious Diseases

Technology Platform

Immunoassays for the Thymidine Kinase 1 (TK1) biomarker, including ELISA and rapid point-of-care formats.

Funding History

2
Total raised:$9.2M
Series A$8M
Seed$1.2M

Opportunities

The growing demand for non-invasive, cost-effective cancer monitoring tools presents a major opportunity, especially in high-growth markets like China and Southeast Asia.
Expanding the clinical utility of the TK1 biomarker into new cancer types and therapy monitoring protocols could significantly broaden the addressable market.

Risk Factors

Commercial success is highly dependent on effective execution through third-party distributors in competitive and regulated international markets.
The company faces competition from other diagnostic technologies and biomarkers, and its growth is tied to the continued clinical validation and adoption of TK1 as a standard monitoring tool.

Competitive Landscape

IDL Diagnostics competes in the crowded oncology diagnostics market, which includes large IVD conglomerates (e.g., Roche, Abbott, Siemens Healthineers) and numerous niche biomarker companies. Its differentiation is based on the specific utility of the TK1 biomarker for monitoring cell proliferation and treatment response, competing against other serum and urine-based tests for cancer surveillance.

More companies in Diagnostics & Precision Medicine →More companies in Sweden →